CytoReason vs ImmunoBrain Checkpoint
CytoReason vs ImmunoBrain Checkpoint, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and ImmunoBrain Checkpoint on 42/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 42/100
- domain rating: 40/100 against 35/100
- headcount: 116 against 18
- LinkedIn following: 12,830 against 1,706
ImmunoBrain Checkpoint
- agent readiness: 36/100 against 21/100
- headcount growth: +17.6% against +13.7%
At a glance
| Measure | CytoReason | ImmunoBrain Checkpoint |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | Biopharmaceutical company targeting neurodegeneration and aging by modulating the immune system. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Immunology, Immunotherapy, Alzheimers |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2016 | 2016 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | CytoReason | ImmunoBrain Checkpoint |
|---|---|---|
| Employees | 116 | 18 |
| Headcount growthLast 12 months | +13.7% | +17.6% |
| Total funding | $128M | Not published |
| Latest round | Series B | Not published |
| LinkedIn followers | 12,830 | 1,706 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | ImmunoBrain Checkpoint |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 42/100 |
| Traction | 60/100 | 13/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 30/100 | 28/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 35/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | ImmunoBrain Checkpoint |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Segment | Google Analytics 4 |
CytoReason vs ImmunoBrain Checkpoint: common questions
Which is better, CytoReason or ImmunoBrain Checkpoint?
On our 0-100 score CytoReason rates higher (68/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do CytoReason and ImmunoBrain Checkpoint compare on the numbers?
CytoReason leads on our overall score (68/100 against 42/100), domain rating (40/100 against 35/100), headcount (116 against 18), LinkedIn following (12,830 against 1,706). ImmunoBrain Checkpoint leads on agent readiness (36/100 against 21/100), headcount growth (+17.6% against +13.7%).
Read the full CytoReason review and pricing or the ImmunoBrain Checkpoint review and pricing. You can also browse other CytoReason alternatives we track.